Evaluation of inferior vena cava wall thickness measured by transthoracic echocardiography as a marker of vascular involvement in Behçet's disease
Öz
Purpose: This study aimed to evaluate inferior vena cava diameter (IVCD) and wall thickness (IVCWT) in patients with Behçet’s disease (BD) using transthoracic echocardiography (TTE), and to investigate their associations with disease activity and vascular involvement. Materials and Methods: This prospective cross-sectional study included 79 patients diagnosed with BD and 84 age- and sex-matched healthy controls. All TTE measurements, including IVCD and IVCWT, were performed during the study period using a standardized protocol. Disease activity was assessed using the Behçet’s Disease Current Activity Form (BDCAF). Subgroup analyses were conducted based on vascular involvement and other clinical characteristics. Results: IVCWT was slightly higher in patients with BD compared with healthy controls (2.35 ± 0.52 mm vs. 2.26 ± 0.57 mm). No meaningful association was identified between disease activity scores and IVC measurements. In contrast, (2.83 ± 0.60 mm vs. 2.28 ± 0.44 mm). Intra-observer reliability was excellent for both IVCWT (ICC = 0.93) and IVC diameter (ICC = 0.91). Conclusion: Increased IVCWT measured by transthoracic echocardiography may indicate vascular involvement in BD independently of overall disease activity. Given its non-invasive nature and high reproducibility, IVCWT could serve as a supportive parameter for identifying subclinical vascular inflammation and guiding individualized follow-up strategies.
Anahtar Kelimeler
Behçet’s Syndrome, Echocardiography, Vascular Diseases, Vena cava inferior
Destekleyen Kurum
Etik Beyan
Teşekkür
Kaynakça
- Feigenbaum A. Description of Behçet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol. 1956;40:355-7.
- Nieto IG, Alabau JLC. Immunopathogenesis of Behçet disease. Curr Rheumatol Rev. 2020;16:12-20.
- Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1-11.
- Hatemi G, Merkel PA, Hamuryudan V, Boccone L, Yazici H, Tugal-Tutkun I et al. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol. 2014;41:599-612.
- Ağackıran SK, Sünbül M, Doğan Z, Bilgin M, Aydın M, Yıldız M et al. Increased inferior vena cava wall thickness as a sign of extensive venous inflammation in Behçet’s disease. Clin Rheumatol. 2024;43:1355-62.
- Alibaz-Oner F, Ergelen R, Yıldız Y, Alioğlu B, Kiraz S, Yazıcı A et al. Femoral vein wall thickness measurement: a new diagnostic tool for Behçet’s disease. Rheumatology (Oxford). 2021;60:288-96.
- Kırmızıer G, Kılınç EA, Varkal G, Özen G, Gündüz S, Aydın S et al. Assessment of pulmonary artery wall thickness by transthoracic echocardiography in Behçet's disease. Mod Rheumatol. 2025;35:916-22.
- Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet’s disease: an update. Curr Opin Rheumatol. 2011;23:24-31.
- International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078-80.
- Hamuryudan V, Fresko I, Direskeneli H, Yazici H, Yurdakul S, Yazici Y et al. Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome. Rheumatology (Oxford). 1999;38:734-6.
